UBS upgrades AJ Bell and raises price target as cost concerns seen overdone

UBS upgraded AJ Bell to buy from neutral and kept its 520p price target (≈20% upside from a 430p reference), arguing recent share weakness overstates cost concerns. UBS expects EPS growth to slow to c.6% in the year to Sept 2026 (from 26% in 2025) as AJ Bell absorbs a c.17% rise in business-as-usual costs including technology and AI investment, but forecasts a recovery to c.15% EPS growth in 2027 and raised earnings forecasts by 6–10% through 2029. The bank also highlighted strong direct-to-consumer net flows, early recovery in the advised channel, robust cash generation and an expected c.£50m/year of share buybacks into the medium term; shares were trading around 438.4p, up ~2% intraday.

Analysis

Market structure: AJ Bell (AJB) is positioned to win retail share if UBS is right — direct-to-consumer net inflows remain strong and management’s willingness to reinvest in pricing combined with a ~£50m p.a. buyback supports EPS even with a 17% step-up in BAU costs in FY26. Competitors with higher cost bases or weaker digital UX (e.g., Hargreaves Lansdown HL.L) face pressure on inflows and pricing power; expect continued fee compression across platforms and faster share gains for lower-cost providers over 12–24 months.

Risk assessment: Key tail risks are a deeper UK equity market drawdown (>-15% index fall over 3–6 months), pension reform delays that prolong adviser outflows, or AI/tech spends failing to produce retention — any could push EPS below UBS’s 6% FY26 forecast. Short-term (days–weeks) price moves will track flows and macro risk-on; medium-term (3–12 months) hinge on net flows and execution of pricing/AI projects; long-term (12–36 months) depends on margin normalisation and buyback continuation.

Trade implications: Direct long in AJB has asymmetric upside: UBS target 520p vs spot ~438p (~+20%); consider 2–3% portfolio exposure sized with 15% stop-loss and 12-month horizon. Pair trades (long AJB, short HL.L) capture relative share-gain and fee compression; options—buy 9–12 month call spreads to cap premium—are preferred if volatility rises.

Contrarian angles: Consensus may understate buybacks’ EPS leverage—£50m p.a. is ~material vs market cap and can offset slower organic growth, making current pricing too pessimistic. Conversely, UBS may be optimistic on market returns; if UK indexes fall back to H1 2025 levels, AJB multiples could rerate lower despite buybacks. Monitor monthly net flows, adviser consolidation announcements, and any FY26 cost overruns as potential reversal catalysts.

Key Decisions for Investors

• Establish a 2–3% long position in AJB (LSE:AJB) at current levels (~430–450p), target 520p within 9–12 months, set a hard stop-loss at 360p (≈-15%) to control execution/AI-risk and market-risk.
• Implement a relative-value pair: long AJB (1.0) vs short Hargreaves Lansdown (HL.L) (0.6–0.8 size) to exploit fee-led share gains; rebalance if monthly net flows diverge by >25% over two consecutive months.
• Buy a 9–12 month AJB call spread (e.g., buy Sep 2026 480p call, sell 600p call) sized to represent 1% portfolio delta—limits premium, captures upside to UBS target while capping cost if sentiment reverses.
• If uncertain on timing, wait for two catalysts before increasing exposure: (A) confirmation of sequential improvement in advised gross inflows (two months of positive upticks) or (B) management guidance on FY27 cost normalisation; both should be observed within 3–6 months.
• Reduce exposure or hedge (buy 3–6 month puts) if UK equity index (FTSE 100/All-Share) declines >10% from current levels or if AJB monthly net flows fall >30% YoY for two consecutive months — those thresholds signal material downside to EPS consensus.